Slow initial β-lactam infusion and oral paracetamol to treat childhood bacterial meningitis: A randomised, controlled trial

The Lancet Infectious Diseases

Volumn 11, Issue 8, 2011, Pages 613-621

  Pelkonen, Tuula ^a,b,d   Roine, Irmeli ^e   Cruzeiro, Manuel Leite ^a   Pitkäranta, Anne ^c,d   Kataja, Matti ^f   Peltola, Heikki ^b,d  

^a Hospital Pediatrico David Bernardino   (Angola)

^b UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e UNIVERSIDAD DIEGO PORTALES   (Chile)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; C REACTIVE PROTEIN; CEFOTAXIME; CHLOROQUINE; DIAZEPAM; GLUCOSE; GLYCEROL; HEMOGLOBIN; IBUPROFEN; PARACETAMOL; PHENOBARBITAL; PLACEBO; PYRIMETHAMINE PLUS SULFADOXINE; QUININE; RINGER SOLUTION;

ADOLESCENT; ARTICLE; ATAXIA; BACTERIAL MENINGITIS; BLOOD CELL COUNT; BLOOD CULTURE; BRAIN MALARIA; CEREBROSPINAL FLUID; CHILD; CHILDHOOD DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CONVULSION; DEATH; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DYSPNEA; FEMALE; FEVER; GRAM STAINING; HAEMOPHILUS INFLUENZAE TYPE B; HEARING IMPAIRMENT; HEMIPARESIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOGLYCEMIA; HYPOVOLEMIA; INFANT; LEUKOCYTE COUNT; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALARIA; MALE; MORTALITY; NEISSERIA MENINGITIDIS; OXYGEN THERAPY; PAIN; PNEUMOCOCCAL MENINGITIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOMOTOR RETARDATION; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHOOL CHILD; SEIZURE; STREPTOCOCCUS PNEUMONIAE; URINALYSIS;

ACETAMINOPHEN; ADOLESCENT; ANGOLA; ANTI-INFECTIVE AGENTS; ANTIPYRETICS; CEFOTAXIME; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GRAM-POSITIVE BACTERIA; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MENINGITIS, BACTERIAL; PROSPECTIVE STUDIES;

EID: 79960697738     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(11)70055-X     Document Type: Article

References (34)

1. Peltola H Burden of meningitis and other severe bacterial infections of children in Africa: implications for prevention. Clin Infect Dis 2001, 32:64-75.
2. Bernardino L, Magalhães J, Simões MJ, Monteiro L Bacterial meningitis in Angola. Lancet 2003, 361:1564-1565.
3. Molyneux E, Riordan FA, Walsh A Acute bacterial meningitis in children presenting to the Royal Liverpool Children's Hospital, Liverpool, UK and the Queen Elizabeth Central Hospital in Blantyre, Malawi: a world of difference. Ann Trop Paediatr 2006, 26:29-37.
4. Peltola H, Anttila M, Renkonen OV Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Lancet 1989, 1:1281-1287. the Finnish Study Group.
5. Odio CM, Faingezicht I, Paris M, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991, 324:1525-1531.
6. Molyneux EM, Walsh AL, Forsyth H, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 2002, 360:211-218.
7. Peltola H, Roine I, Fernandez J, et al. Hearing impairment in childhood bacterial meningitis is little relieved by dexamethasone or glycerol. Pediatrics 2010, 125:e1-e8.
8. van de Beek D, Farrar JJ, de Gans J, et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol 2010, 9:254-263.
9. Peltola H, Roine I, Fernandez J, et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2007, 45:1277-1286.
10. Craig WA, Ebert SC Continuous infusion of beta-lactam antibiotics. Antimicrob Agents Chemother 1992, 36:2577-2583.
11. Mustafa MM, Ramilo O, Mertsola J, et al. Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis. J Infect Dis 1989, 160:818-825.
12. Tuomanen E, Liu H, Hengstler B, Zak O, Tomasz A The induction of meningeal inflammation by components of the pneumococcal cell wall. J Infect Dis 1985, 151:859-868.
13. Nau R, Eiffert H Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis. Clin Microbiol Rev 2002, 15:95-110.
14. Cozens RM, Tuomanen E, Tosch W, Zak O, Suter J, Tomasz A Evaluation of the bactericidal activity of beta-lactam antibiotics on slowly growing bacteria cultured in the chemostat. Antimicrob Agents Chemother 1986, 29:797-802.
15. Lipman J, Gomersall CD, Gin T, Joynt GM, Young RJ Continuous infusion ceftazidime in intensive care: a randomized controlled trial. J Antimicrob Chemother 1999, 43:309-311.
16. Nicolau DP, McNabb J, Lacy MK, Quintiliani R, Nightingale CH Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia. Int J Antimicrob Agents 2001, 17:497-504.
17. Kasiakou SK, Sermaides GJ, Michalopoulos A, Soteriades ES, Falagas ME Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials. Lancet Infect Dis 2005, 5:581-589.
18. Roberts JA, Boots R, Rickard CM, et al. Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study. J Antimicrob Chemother 2007, 59:285-291.
19. van Zanten AR, Oudijk M, Nohlmans-Paulssen MK, van der Meer YG, Girbes AR, Polderman KH Continuous vs. intermittent cefotaxime administration in patients with chronic obstructive pulmonary disease and respiratory tract infections: pharmacokinetics/pharmacodynamics, bacterial susceptibility and clinical efficacy. Br J Clin Pharmacol 2007, 63:100-109.
20. Roberts JA, Roberts MS, Robertson TA, Dalley AJ, Lipman J Piperacillin penetration into tissue of critically ill patients with sepsis-bolus versus continuous administration?. Crit Care Med 2009, 37:926-933.
21. Kuikka A, Sivonen A, Emelianova A, Valtonen VV Prognostic factors associated with improved outcome of Escherichia coli bacteremia in a Finnish university hospital. Eur J Clin Microbiol Infect Dis 1997, 16:125-134.
22. Kuikka A, Valtonen VV Factors associated with improved outcome of Pseudomonas aeruginosa bacteremia in a Finnish university hospital. Eur J Clin Microbiol Infect Dis 1998, 17:701-708.
23. Spreer A, Lugert R, Stoltefaut V, Hoecht A, Eiffert H, Nau R Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis. Crit Care Med 2009, 37:2253-2258.
24. Hitt CM, Nightingale CH, Quintiliani R, Nicolau DP Cost comparison of single daily i.v. doses of ceftriaxone versus continuous infusion of cefotaxime. Am J Health Syst Pharm 1997, 54:1614-1618.
25. Klepser ME, Patel KB, Nicolau DP, Quintiliani R, Nightingale CH Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis. Pharmacotherapy 1998, 18:1069-1074.
26. Bernard GR, Wheeler AP, Russell JA, et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 1997, 336:912-918.
27. Piletta P, Porchet HC, Dayer P Central analgesic effect of acetaminophen but not of aspirin. Clin Pharmacol Ther 1991, 49:350-354.
28. Aronoff DM, Oates JA, Boutaud O New insights into the mechanism of action of acetaminophen: its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases. Clin Pharmacol Ther 2006, 79:9-19.
29. Kramer MS, Naimark LE, Roberts-Brauer R, McDougall A, Leduc DG Risks and benefits of paracetamol antipyresis in young children with fever of presumed viral origin. Lancet 1991, 337:591-594.
30. Brandts CH, Ndjave M, Graninger W, Kremsner PG Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet 1997, 350:704-709.
31. Udomsangpetch R, Pipitaporn B, Silamut K, et al. Febrile temperatures induce cytoadherence of ring-stage Plasmodium falciparum-infected erythrocytes. Proc Natl Acad Sci USA 2002, 99:11825-11829.
32. Prymula R, Siegrist CA, Chlibek R, et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. Lancet 2009, 374:1339-1350.
33. Pelkonen T, Roine I, Monteiro L, et al. Acute childhood bacterial meningitis in Luanda, Angola. Scand J Infect Dis 2008, 40:859-866.
34. Pelkonen T, Roine I, Monteiro L, et al. Risk factors for death and severe neurological sequelae in childhood bacterial meningitis in sub-Saharan Africa. Clin Infect Dis 2009, 48:1107-1110.